Literature DB >> 19939928

Fusion-deficient insertion mutants of herpes simplex virus type 1 glycoprotein B adopt the trimeric postfusion conformation.

Jessica L Silverman1, Sapna Sharma, Tina M Cairns, Ekaterina E Heldwein.   

Abstract

Glycoprotein B (gB) enables the fusion of viral and cell membranes during entry of herpesviruses. However, gB alone is insufficient for membrane fusion; the gH/gL heterodimer is also required. The crystal structure of the herpes simplex virus type 1 (HSV-1) gB ectodomain, gB730, has demonstrated similarities between gB and other viral fusion proteins, leading to the hypothesis that gB is a fusogen, presumably directly involved in bringing the membranes together by refolding from its initial or prefusion form to its final or postfusion form. The only available crystal structure likely represents the postfusion form of gB; the prefusion form has not yet been determined. Previously, a panel of HSV-1 gB mutants was generated by using random 5-amino-acid-linker insertion mutagenesis. Several mutants were unable to mediate cell-cell fusion despite being expressed on the cell surface. Mapping of the insertion sites onto the crystal structure of gB730 suggested that several insertions might not be accommodated in the postfusion form. Thus, we hypothesized that some insertion mutants were nonfunctional due to being "trapped" in a prefusion form. Here, we generated five insertion mutants as soluble ectodomains and characterized them biochemically. We show that the ectodomains of all five mutants assume conformations similar to that of the wild-type gB730. Four mutants have biochemical properties and overall structures that are indistinguishable from those of the wild-type gB730. We conclude that these mutants undergo only minor local conformational changes to relieve the steric strain resulting from the presence of 5 extra amino acids. Interestingly, one mutant, while able to adopt the overall postfusion structure, displays significant conformational differences in the vicinity of fusion loops, relative to wild-type gB730. Moreover, this mutant has a diminished ability to associate with liposomes, suggesting that the fusion loops in this mutant have decreased functional activity. We propose that these insertions cause a fusion-deficient phenotype not by preventing conversion of gB to a postfusion-like conformation but rather by interfering with other gB functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939928      PMCID: PMC2812406          DOI: 10.1128/JVI.01791-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; Don C Wiley; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.

Authors:  Claude Krummenacher; Frédéric Baribaud; Manuel Ponce de Leon; Isabelle Baribaud; J Charles Whitbeck; Ruliang Xu; Gary H Cohen; Roselyn J Eisenberg
Journal:  Virology       Date:  2004-05-01       Impact factor: 3.616

3.  Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops.

Authors:  Brian P Hannah; Tina M Cairns; Florent C Bender; J Charles Whitbeck; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

4.  Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1.

Authors:  C G Miller; C Krummenacher; R J Eisenberg; G H Cohen; N W Fraser
Journal:  Mol Ther       Date:  2001-02       Impact factor: 11.454

5.  Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change.

Authors:  R W Doms; A Helenius; J White
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

6.  Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate.

Authors:  P E Pertel; A Fridberg; M L Parish; P G Spear
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

7.  Herpes simplex virus gD forms distinct complexes with fusion executors gB and gH/gL in part through the C-terminal profusion domain.

Authors:  Tatiana Gianni; Michele Amasio; Gabriella Campadelli-Fiume
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

8.  Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; Don C Wiley; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B.

Authors:  Marija Backovic; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

Review 10.  Viral membrane fusion.

Authors:  Stephen C Harrison
Journal:  Nat Struct Mol Biol       Date:  2008-07       Impact factor: 15.369

View more
  11 in total

1.  Residues within the C-terminal arm of the herpes simplex virus 1 glycoprotein B ectodomain contribute to its refolding during the fusion step of virus entry.

Authors:  Sarah A Connolly; Richard Longnecker
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

2.  Membrane requirement for folding of the herpes simplex virus 1 gB cytodomain suggests a unique mechanism of fusion regulation.

Authors:  Jessica L Silverman; Neil G Greene; David S King; Ekaterina E Heldwein
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1.

Authors:  Samuel D Stampfer; Huan Lou; Gary H Cohen; Roselyn J Eisenberg; Ekaterina E Heldwein
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

Review 5.  The structural basis of herpesvirus entry.

Authors:  Sarah A Connolly; Theodore S Jardetzky; Richard Longnecker
Journal:  Nat Rev Microbiol       Date:  2020-10-21       Impact factor: 60.633

6.  The Epstein-Barr virus (EBV) glycoprotein B cytoplasmic C-terminal tail domain regulates the energy requirement for EBV-induced membrane fusion.

Authors:  Jia Chen; Xianming Zhang; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

7.  Extensive mutagenesis of the HSV-1 gB ectodomain reveals remarkable stability of its postfusion form.

Authors:  Elvira Vitu; Sapna Sharma; Samuel D Stampfer; Ekaterina E Heldwein
Journal:  J Mol Biol       Date:  2013-03-13       Impact factor: 5.469

8.  HCMV gB shares structural and functional properties with gB proteins from other herpesviruses.

Authors:  Sapna Sharma; Todd W Wisner; David C Johnson; Ekaterina E Heldwein
Journal:  Virology       Date:  2012-10-22       Impact factor: 3.616

9.  The membrane-proximal region (MPR) of herpes simplex virus gB regulates association of the fusion loops with lipid membranes.

Authors:  Spencer S Shelly; Tina M Cairns; J Charles Whitbeck; Huan Lou; Claude Krummenacher; Gary H Cohen; Roselyn J Eisenberg
Journal:  MBio       Date:  2012-11-20       Impact factor: 7.867

10.  Rapid genome assembly and comparison decode intrastrain variation in human alphaherpesviruses.

Authors:  Lance R Parsons; Yolanda R Tafuri; Jacob T Shreve; Christopher D Bowen; Mackenzie M Shipley; L W Enquist; Moriah L Szpara
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.